Experimental and Molecular Pathology: 2022, vol: 128, issue:
1)- Laurie B Joseph, Marion K Gordon, Peihong Zhou, Rita A Hahn, Hamdi Lababidi, Claire R Croutch, Patrick J Sinko, Diane E Heck, Debra L Laskin, Jeffrey D Laskin. Sulfur mustard corneal injury is associated with alterations in the epithelial basement membrane and stromal extracellular matrix.Experimental and molecular pathology. 2022, 128: 104807
2)- June K Dunnick, Arun R Pandiri, Keith R Shockley, Ronald Herbert, Deepak Mav, Dhiral Phadke, Ruchir R Shah, B Alex Merrick. Single nucleotide polymorphism patterns associated with a cancer resistant phenotype.Experimental and molecular pathology. 2022, 128: 104812
3)- Ashley Gray, Tiantian Cui, Erica Hlavin Bell, Joseph McElroy, Ebin Sebastian, Fuhai Li, Marjolein Geurts, Kevin Liu, Pierre Robe, S Jaharul Haque, Arnab Chakravarti. MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma.Experimental and molecular pathology. 2022, 128: 104813
4)- Sepideh Kadkhoda, Soudeh Ghafouri-Fard, Farshid Noorbakhsh, Sima Ravaei, Farzaneh Darbeheshti, Mahsa M Amoli, Reza Taslimi, Abbas Shakoori. The importance of regulatory pathway mediated by Circ0001955 in colorectal cancer.Experimental and molecular pathology. 2022, 128: 104819
5)- Marija S Stankovic, Silvio R De Luka, Sasa Jankovic, Srdjan Stefanovic, Maja Stojanovic, Jelena Nesovic-Ostojic, Nina Japundzic-Zigon, Alexander M Trbovich. ST2 and the alteration of cobalt, sodium, potassium and calcium concentration in acute inflammation.Experimental and molecular pathology. 2022, 128: 104820
7)- Stephen E Fry, Mitchell Kaye, Dara S Missan, Christian Becker, Matthew Shabilla, Delyn Martinez, Erin Bossert, Jeremy Ellis. Microbial community profiling by next-generation DNA sequencing of adenocarcinoma of the prostate with evidence of ochratoxin A producing fungi.Experimental and molecular pathology. 2022, 128: 104831
8)- Weijie Xue, Bingzi Dong, Yixiu Wang, Yuwei Xie, Pu Li, Zhiqi Gong, Zhaojian Niu. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options.Experimental and molecular pathology. 2022, 128: 104832
9)- Annamaria Salvati, Ileana Carnevali, Elena Alexandrova, Sofia Facchi, Susanna Ronchi, Laura Libera, Nora Sahnane, Domenico Memoli, Jessica Lamberti, Sonia Amabile, Stefano Pepe, Roberta Tarallo, Fausto Sessa, Alessandro Weisz, Maria Grazia Tibiletti, Francesca Rizzo. Targeted molecular profiling of epithelial ovarian cancer from Italian BRCA wild-type patients with a BRCA and PARP pathways gene panel.Experimental and molecular pathology. 2022, 128: 104833
10)- Nihal Salah Ibrahim, Manal Mohamed Makhlouf, Gehan Hamed Shahin, Mona Kamal Elghamrawy, Nehad Mohammed Hussein. The impact of MCP1-2518A/G and CCR2-V64I genetic polymorphisms in Egyptian sickle cell disease patients.Experimental and molecular pathology. 2022, 128: 104834
12)- Hava Kuçuk, David Laville, Pierre Dal-Col, Violaine Yvorel, Abdulrazzak Sulaiman, Sophie Bayle-Bleuez, Philippe Cosmo, Jean-Michel Vergnon, Olivier Tiffet, Anne-Laure Desage, Fabien Forest. Value of immunohistochemistry in crushed areas of pulmonary neuroendocrine carcinoma.Experimental and molecular pathology. 2022, 128: 104836